Bruton's Tyrosine Kinase Regulates TLR9 but not TLR7 Signaling in Human pDCs

pDCs from healthy donors (n=4) were treated with gardiquimod (TLR7 agonist) or ODN 2216 (TLR9 agonist) with or without BTK inhibitor for 3 hours.